122 related articles for article (PubMed ID: 26191165)
1. miR-182 induces cervical cancer cell apoptosis through inhibiting the expression of DNMT3a.
Sun J; Ji J; Huo G; Song Q; Zhang X
Int J Clin Exp Pathol; 2015; 8(5):4755-63. PubMed ID: 26191165
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of DNMT3a expression increases miR-182-induced apoptosis of ovarian cancer through caspase-3 and caspase-9-mediated apoptosis and DNA damage response.
Lu W; Lu T; Wei X
Oncol Rep; 2016 Dec; 36(6):3597-3604. PubMed ID: 27748882
[TBL] [Abstract][Full Text] [Related]
3. [miR-101 inhibits the proliferation and migration of breast cancer cells via downregulating the expression of DNA methyltransferase 3a].
Liu J; Pang Y; Wang H; Li Y; Sun X; Xu F; Ren H; Liu D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):299-303. PubMed ID: 26927545
[TBL] [Abstract][Full Text] [Related]
4. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A.
Wei X; Xiang T; Ren G; Tan C; Liu R; Xu X; Wu Z
Cell Signal; 2013 Feb; 25(2):439-46. PubMed ID: 23124077
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-744 inhibited cervical cancer growth and progression through apoptosis induction by regulating Bcl-2.
Chen XF; Liu Y
Biomed Pharmacother; 2016 Jul; 81():379-387. PubMed ID: 27261616
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
7. The mechanisms involved in miR-9 regulated apoptosis in cervical cancer by targeting FOXO3.
Zhang H; Zhang Z; Wang S; Zhang S; Bi J
Biomed Pharmacother; 2018 Jun; 102():626-632. PubMed ID: 29602130
[TBL] [Abstract][Full Text] [Related]
8. miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells.
Yang L; Wang YL; Liu S; Zhang PP; Chen Z; Liu M; Tang H
FEBS Lett; 2014 Jan; 588(1):124-30. PubMed ID: 24269684
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors inducing human cervical cancer cell apoptosis by decreasing DNA-methyltransferase 3B.
Liu N; Zhao LJ; Li XP; Wang JL; Chai GL; Wei LH
Chin Med J (Engl); 2012 Sep; 125(18):3273-8. PubMed ID: 22964322
[TBL] [Abstract][Full Text] [Related]
10. miR-429 is involved in regulation of NF-κBactivity by targeting IKKβ and suppresses oncogenic activity in cervical cancer cells.
Fan JY; Fan YJ; Wang XL; Xie H; Gao HJ; Zhang Y; Liu M; Tang H
FEBS Lett; 2017 Jan; 591(1):118-128. PubMed ID: 27883176
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
Yao Q; Xu H; Zhang QQ; Zhou H; Qu LH
Biochem Biophys Res Commun; 2009 Oct; 388(3):539-42. PubMed ID: 19682430
[TBL] [Abstract][Full Text] [Related]
12. miR-187 induces apoptosis of SiHa cervical carcinoma cells by downregulating Bcl-2.
He CY; Yang J
Genet Mol Res; 2017 Jan; 16(1):. PubMed ID: 28128400
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance.
Yang Y; Xie YJ; Xu Q; Chen JX; Shan NC; Zhang Y
Gynecol Oncol; 2015 Sep; 138(3):683-8. PubMed ID: 26074491
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-143 inhibits growth and induces apoptosis in human leukemia cells.
Shen JZ; Zhang YY; Fu HY; Wu DS; Zhou HR
Oncol Rep; 2014 May; 31(5):2035-42. PubMed ID: 24626955
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-18a enhances the radiosensitivity of cervical cancer cells by promoting radiation-induced apoptosis.
Liu S; Pan X; Yang Q; Wen L; Jiang Y; Zhao Y; Li G
Oncol Rep; 2015 Jun; 33(6):2853-62. PubMed ID: 25963391
[TBL] [Abstract][Full Text] [Related]
17. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene.
Ke G; Liang L; Yang JM; Huang X; Han D; Huang S; Zhao Y; Zha R; He X; Wu X
Oncogene; 2013 Jun; 32(25):3019-27. PubMed ID: 22847611
[TBL] [Abstract][Full Text] [Related]
18. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
Wang N; Zhou Y; Zheng L; Li H
Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
[TBL] [Abstract][Full Text] [Related]
19. MiR-495 suppresses mesendoderm differentiation of mouse embryonic stem cells via the direct targeting of Dnmt3a.
Yang D; Wang G; Zhu S; Liu Q; Wei T; Leng Y; Duan T; Kang J
Stem Cell Res; 2014 Mar; 12(2):550-61. PubMed ID: 24530979
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma.
Luczak MW; Roszak A; Pawlik P; Kędzia H; Kędzia W; Malkowska-Walczak B; Lianeri M; Jagodziński PP
Int J Oncol; 2012 Mar; 40(3):860-6. PubMed ID: 21887463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
